We are excited to highlight Eike's pivotal role in the DEFENDER consortium, a collaborative effort focused on uncovering viral entry factors. His research is vital in developing targeted strategies for preventing and controlling yellow fever virus (YFV) infections 🦟.
04.04.2025 08:42 — 👍 0 🔁 1 💬 0 📌 0
Eike Steinmann heads the Department of Molecular & Medical Virology at @ruhr-uni-bochum.de 🧬. His team is at the forefront of groundbreaking research, exploring RNA virus replication mechanisms and transmission routes, with a focus on flavi- and coronaviruses.
04.04.2025 08:41 — 👍 2 🔁 1 💬 3 📌 0
Spotlight on Marie Flamand
Meet Marie, a virologist leading groundbreaking research at @institutpasteur.bsky.social Paris. Marie and her team have already made waves in understanding how dengue, Zika, and Rift Valley fever viruses impact human health.
10.04.2025 06:50 — 👍 0 🔁 1 💬 3 📌 0
We're excited to share a recent SWR NANO feature highlighting DEFENDER that takes us behind the scenes of the impressive work done by the @chlandalab.bsky.social Lab at @uniheidelberg.bsky.social! 🧬 The feature starts at minute 18:58 – be sure to tune in!
👉 www.3sat.de/wissen/nano/...
10.04.2025 08:01 — 👍 1 🔁 1 💬 0 📌 0
✨ Spotlight on @kreylab.bsky.social ! ✨
🧪 At the Universität zu Lübeck, DEFENDER PI Thomas Krey and his team are at the forefront of structural virology, investigating how viral glycoproteins interact with the immune system and how virus capsids assemble.
18.03.2025 20:20 — 👍 0 🔁 1 💬 2 📌 0
Our goal? To advance our understanding of host-pathogen interactions and uncover new viral entry factors, paving the way for innovative antiviral strategies against viral diseases with epidemic potential.
13.03.2025 11:15 — 👍 3 🔁 2 💬 0 📌 0
In the coming weeks, we’ll introduce you to the outstanding partners in our consortium – leading experts in virology, structural biology, and drug development – who are driving this crucial research forward. Stay tuned to learn more about their expertise and contributions!
13.03.2025 11:15 — 👍 3 🔁 2 💬 0 📌 0
DEFENDER
The DEFENDER project has officially launched!
We are excited to kick off DEFENDER (Identification of Novel Viral Entry Factors and Development of Antiviral Approaches), an EU-funded initiative under the 2024-DISEASE-08-20 call, focused on pandemic preparedness and response.
🔗 defender-project.org
13.03.2025 10:56 — 👍 4 🔁 2 💬 2 📌 0
The deadline to apply for a travel grant to attend the CSSB symposium is this Friday, February 28.
To apply for the travel grant please complete the registration form and submit your scientific abstract.
symposium2025.cssb-hamburg.de/registration
@leibnizliv.bsky.social @uni-hamburg.de @embl.org
26.02.2025 09:12 — 👍 4 🔁 6 💬 0 📌 0
Congrats to George Ssebyatika and Katja DInkelburg!!!!!!
26.02.2025 19:02 — 👍 1 🔁 0 💬 0 📌 1
Happy to join the Bluesky community! 🎉 Will try to share exciting research results, interesting events, announcements and reports about our research activities ...
16.01.2025 10:03 — 👍 5 🔁 0 💬 0 📌 0
Linking protein structure to function and mechanisms in virology. https://virologie-ccm.charite.de/forschung/ag_bogdanow
Focuses on immune responses, pathogenesis, and viral infection/replication mechanisms of human pathogens infecting the liver, including hepatitis B (HBV) and C viruses (HCV), Zika, yellow fever and Dengue #viruses, and plasmodial parasites at #princeton
Official account of the American Society for Microbiology. With over 38,000 members, ASM's mission is to promote & advance the microbial sciences.
Rosetta Commons is the central hub for hundreds of developers and scientists from ~100 universities and laboratories to contribute and share the Rosetta source code.
Rosetta Commons members develop software improvements to solve their unique queries.
Developing macromolecular structure resources and tools for life science.
- Founding partner of the wwPDB.
- Manage the community-led PDBe-KB resource and the AlphaFold Protein Structure Database, a collaboration with Google DeepMind.
- Part of EMBL-EBI
RCSB PDB (RCSB.org) promotes a structural view of biology. Funded by NSF, NCI, NIAID, NIGMS, NIH, and DOE
Director, Geneva Centre for Emerging Viral Diseases - Virologist, MD, DTM&H. Interests: Emerging viruses, coronaviruses, diagnostics, translational research for better preparedness for epidemic & pandemic viruses.
Views are my own.
Young and dynamic research group @LMU working on innate immunity against retroviruses and cancer; www.viirallab.com
Head of Infection Biology Unit at RWTH Aachen University, speaker of @spp2225.bsky.social, speaker and founder of @infect-net.bsky.social
Prof. of Biochemistry at UKE. Interested in molecular basis of bacterial infections. Views are my own.
Virologist at Gladstone Institute.
Center of Excellence at Aarhus University (@au.dk) & TU Munich (@tum.de), focused on discovering novel #immune response mechanisms against #viral #infections. Funded by Danmarks Grundforsk Fond (@dg.dk).
https://biomed.au.dk/civia
We (The World Health Organization) are the United Nations’ health agency championing Health For All. Always check the latest posts for updated advice/information. We will remove misinformation, spam, and hate speech here.
EMBL's European Bioinformatics Institute (EMBL-EBI) provides open biological data resources and tools, and performs basic research in computational biology. https://www.ebi.ac.uk/
Nature Microbiology publishes the latest research and commentary in all areas of microbiology.
https://www.nature.com/nmicrobiol/
Scientist and Deputy Editor, Cell at Cell Press
All things science with a love for #microbes, #immunology & #metabolism #sciencesky #womeninSTEM - Opinions and posts are my own. 🇺🇸🇮🇳
https://www.cell.com/cell/editors-and-staff
Non-profit publisher of @embojournal.org, @emboreports.org, @embomolmed.org, @molsystbiol.org and @lsajournal.org. #OpenScience #Policy
Welcome to the official Bluesky account for the New England Journal of Medicine. Follow for high-quality, peer-reviewed research and clinical content from the world’s leading medical journal, online at NEJM.org.
Follow @ai.nejm.org for medical AI content.
